National Cancer Institute funding for rapid cycle interventional research in cancer care delivery
JNCI Cancer Spectrum · 31.10.2023 · 7 (6)
DOI: 10.1093/jncics/pkad089 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 20.10.2023. Verfasst von Wynne E Norton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. Hauptthemen laut MEDLINE: Biomedical Research, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Rapid cycle interventional research can accelerate improvements to cancer care delivery and patient health outcomes by answering multiple questions as part of a single research study. To complement ongoing efforts to increase awareness of and support for rapid cycle interventional research, we conducted a systematic portfolio analysis of research grants funded by the National Cancer Institute on the topic.
Methods
We used standard portfolio analytic methods for identifying, coding, and synthesizing rapid cycle interventional research funded by the National Cancer Institute between 2016 and 2022. A codebook was used to standardize assessment of the grants by common study characteristics, intervention topics, and cancer care delivery context.
Results
We identified 26 grants, mostly funded since 2019, as rapid cycle interventional research. Most studies included adult or older adult target populations, used electronic systems for intervention delivery, and focused primarily on testing different components of interventions. Studies also used a range of study designs, intervention content areas, cancer sites, and across the cancer control continuum.
Conclusions
The current portfolio analysis of funded rapid cycle interventional research grants suggests a growing albeit relatively small number of studies in this area. Several efforts are needed to continue to grow this area of research, including training programs, funding opportunities, and strengthening research-practice partnerships. This analysis provides a snapshot of current studies and highlights the opportunity for growing this important area of research to optimize cancer care delivery and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
ORCID-Profile: Wynne E Norton
Zitieren
APA
Norton, W. E., Neta, G., & Jacobsen, P. B. (2023). National Cancer Institute funding for rapid cycle interventional research in cancer care delivery. JNCI Cancer Spectrum, 7(6). https://doi.org/10.1093/jncics/pkad089
Vancouver
Norton WE, Neta G, Jacobsen PB. National Cancer Institute funding for rapid cycle interventional research in cancer care delivery. JNCI Cancer Spectrum. 2023;7(6). doi:10.1093/jncics/pkad089
BibTeX
@article{Norton2023,
author = {Norton, Wynne E and Neta, Gila and Jacobsen, Paul B},
title = {National Cancer Institute funding for rapid cycle interventional research in cancer care delivery},
journal = {JNCI Cancer Spectrum},
year = {2023},
volume = {7},
number = {6},
doi = {10.1093/jncics/pkad089}
}
EUVIMED